The Clay Travis and Buck Sexton Show
Special Segment: Wellness Unmasked Weekly Rundown with Dr. Nicole Safire
Episode Date: March 12, 2026
Produced by: iHeartPodcasts
Episode Overview
This special segment of The Clay Travis and Buck Sexton Show features Dr. Nicole Safire delivering her "Wellness Unmasked Weekly Rundown." The episode spotlights two pressing health issues: the alarming presence of microplastics in the brain and the controversial push to prescribe GLP-1 weight loss drugs to increasingly younger children. Dr. Safire unpacks the latest research, shares practical advice, and issues strong warnings about misguided approaches to pediatric obesity.
Key Discussion Points
1. Microplastics and Brain Health
Timestamps: [02:04] – [03:40]
-
New Research:
- Dr. Safire highlights a "massive literature review examining more than 100 studies" on the effects of micro- and nanoplastics in the human body.
- Key concern: Microplastics, found everywhere—from food and water to air and even clothing—can trigger "neuroinflammation and certain proteins clumping in the brain," the same protein clumps seen in Parkinson's disease.
- Quote:
"These same protein clumps that are associated with Parkinson's disease... There's a lot of research that shows microplastics and nanoplastics in our brain, in our gut, they're disrupting our hormones, potentially causing levels of infertility and other things."
(Dr. Nicole Safire, [02:23])
-
Current Scientific Consensus:
- Emphasizes that correlations—not causations—are being observed.
- The call is for awareness, not panic.
-
Practical Takeaways:
- Avoid heating food in plastic containers; use "glass containers or even stainless steels."
- Wear natural clothes instead of synthetic athletic wear to reduce exposure.
- Use water filters for cleaner water, but "they are not good enough to replace and filter out the nanoparticles." Sourcing the cleanest water available is recommended.
-
Summary Advice:
- "The time is now to start lowering your exposure." (Dr. Nicole Safire, [03:39])
2. The Push for GLP-1 Weight Loss Drugs in Young Children
Timestamps: [03:41] – [05:54]
-
Industry Developments:
- Pharmaceutical companies are trialing GLP-1 medications in children as young as 4.
- These drugs are already FDA-approved for children 12+ and widely used among adults.
-
Statistical Context:
- "Nearly one in five American children are obese." (Dr. Nicole Safire, [04:02])
-
Concerns and Warnings:
- Dr. Safire voices strong opposition to using these medications in young kids:
- GLP-1 medications are normally designed for "lifelong and long term use."
- Weight regained once medication stops is a common problem.
- Critical developmental risks: "These medications cause nutrient depletion. If you're depleting nutrients in kids that are still developing, how will it impact their brain health, their muscle health, their bone health, their hormones, hormonal health? Is it gonna even increase the rates of infertility? My guess is probably yes." (Dr. Nicole Safire, [04:23])
- Dr. Safire voices strong opposition to using these medications in young kids:
-
Underlying Issues:
- Dr. Safire stresses the need to instill healthy foundations—nutrition, physical activity, sleep, reduced toxin exposure, less screen time—rather than rely on "lifelong expensive medications."
- Quote:
"If we're not teaching kids healthy behaviors when they're in elementary school, how can we expect them to ever adopt these healthy behaviors as they get older?"
(Dr. Nicole Safire, [04:40])
-
Limited Place for Pharmaceuticals:
- Medications may have a role in rare instances (e.g., children with metabolic disorders), but they are not a suitable long-term solution for the general pediatric population.
-
Dr. Safire’s Stance:
- "Absolutely not prescribing lifelong expensive medications to children. I think that there'll be severe short term and long term consequences and I am staunchly opposed to these medications being used in younger people." (Dr. Nicole Safire, [05:35])
Notable Quotes
-
On Microplastics:
"There's a lot of research that shows microplastics and nanoplastics in our brain, in our gut, they're disrupting our hormones, potentially causing levels of infertility and other things."
(Dr. Nicole Safire, [02:23]) -
On Practical Precautions:
"Try to use glass containers or even stainless steels. You can stop wearing those synthetic athletic clothes... try to use more natural clothes. Water filters are always great to help give us clean water, but the reality is they are not good enough to replace and filter out the nanoparticles."
(Dr. Nicole Safire, [03:07]) -
On GLP-1 Use in Children:
"If you're depleting nutrients in kids that are still developing, how will it impact their brain health, their muscle health, their bone health, their hormones, hormonal health? Is it gonna even increase the rates of infertility? My guess is probably yes."
(Dr. Nicole Safire, [04:23]) -
Foundational Lessons:
"If we're not teaching kids healthy behaviors when they're in elementary school, how can we expect them to ever adopt these healthy behaviors as they get older?"
(Dr. Nicole Safire, [04:40]) -
Position Statement:
"Absolutely not prescribing lifelong expensive medications to children. I think that there'll be severe short term and long term consequences and I am staunchly opposed to these medications being used in younger people."
(Dr. Nicole Safire, [05:35])
Key Takeaways
-
On Microplastics:
- Research is accumulating about the dangers of micro- and nanoplastics for brain health, but direct causation is not yet proven.
- Take immediate, reasonable steps to reduce exposure from food containers, clothing, and water sources.
-
On Childhood Obesity and GLP-1 Drugs:
- While childhood obesity is a serious issue, aggressive pharmaceutical intervention in very young children is fraught with unresolved risks.
- Real, lasting change depends on foundational lifestyle habits, not long-term reliance on medication.
Listeners interested in these topics should seek reputable sources for further reading and maintain a focus on practical, sustainable health choices for themselves and their families.
